Platelet-activating factor acetylhydrolase gene mutation in Japanese children with Escherichia coli O157-associated hemolytic uremic syndrome

American Journal of Kidney Diseases

Volumn 36, Issue 1, 2000, Pages 42-46

  Xu, H ^a,b,c,d   Iijima, Kazumoto ^a,b,c,d   Shirakawa, Taku ^a,b,c,d   Shiozawa, Shunichi ^a,b,c,d   Miwa, Masao ^a,b,c,d   Yamaoka, Kanji ^a,b,c,d   Kawamura, Naohisa ^a,b,c,d   Nakamura, Hajime ^a,b,c,d   Yoshikawa, Norishige ^a,b,c,d  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

^c OSAKA GENERAL MEDICAL CENTER   (Japan)

^d OSAKA ROSAI HOSPITAL   (Japan)

Author keywords

Escherichia coli O157; Gene mutation; Hemolytic uremic syndrome (HUS); Platelet activating factor (PAF); Platelet activating factor (PAF) acetylhydrolase

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DIALYSIS; DISEASE SEVERITY; ENZYME ACTIVITY; ESCHERICHIA COLI O157; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; HEMOLYTIC UREMIC SYNDROME; HETEROZYGOSITY; HUMAN; JAPAN; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD;

EID: 0033933809     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2000.8262     Document Type: Article

References (34)

1. SE Richardson MA Karmali LE Becker CR Smith The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections Hum Pathol 19 1988 1102 1108
2. JL Moake JJ Byrnes JH Troll CK Rudy MJ Weinstein NM Colannino SL Hong Abnormal VIII:von Willebrand factor patterns in the plasma of patients with the hemolytic uremic syndrome Blood 64 1984 592 598
3. P Ruggenenti The hemolytic uremic syndrome Kidney Int 47 1995 2 19
4. GH Neild Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura: Pathophysiology and treatment Kidney Int 53 suppl 64 1998 S45 S49
5. PA van Setten VWM van Hinsbergh LPWJ van den Heuvel F Preyers HBPM Dijkman KJM Assmann TJ van der Velden LA Monnens Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patients with hemolytic uremic syndrome Pediatr Res 43 1998 759 767
6. SM Prescott GA Zimmerman TM McIntyre Platelet-activating factor J Biol Chem 265 1990 17381 17384
7. TA Imaizumi DM Stafforini Y Yamada TM McIntyre SM Prescott GA Zimmerman Platelet-activating factor: A mediator for clinicians J Intern Med 238 1995 5 20
8. NG Bazan A signal terminator Nature 374 1995 501 502
9. D Schlondorff R Neuwirth Platelet-activating factor and the kidney Am J Physiol 251 1986 F1 F11
10. C Zoja G Remuzzi Role of platelets in progressive glomerular diseases Pediatr Nephrol 9 1995 495 502
11. EA Lianos A Zanglis Glomerular platelet-activating factor levels and origin in experimental glomerulonephritis Kidney Int 37 1990 736 740
12. N Perico F Delaini M Tagliaferri M Abbate M Cucchi T Bertani G Remuzzi Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney Lab Invest 58 1988 163 171
13. A Benigni P Boccardo M Noris G Remuzzi RL Siegler Urinary excretion of platelet-activating factor in haemolytic uraemic syndrome Lancet 339 1992 835 836
14. DM Stafforini SM Prescott TM McIntyre Human plasma platelet-activating factor acetylhydrolase. Purification and properties J Biol Chem 262 1987 4223 4230
15. DM Stafforini SM Prescott GA Zimmerman TM McIntyre Platelet-activating factor acetylhydrolase activity in human tissues and blood cells Lipids 26 1991 979 985
16. C Tetta F Bussolino V Modena G Montrucchio G Segoloni G Pescarmona G Camussi Release of platelet-activating factor in systemic lupus erythematosus Int Arch Allergy Appl Immunol 91 1990 244 256
17. RM Graham CJ Stephens W Silvester LL Leong MJ Sturm RR Taylor Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis Crit Care Med 22 1994 204 212
18. DM Stafforini EN Rollins SM Prescott TM McIntyre The platelet-activating factor acetylhydrolase from human erythrocytes. Purification and properties J Biol Chem 268 1993 3857 3865
19. B Kirschbaum Platelet-activating factor acetylhydrolase activity in the urine of patients with renal disease Clin Chi Acta 199 1991 139 146
20. M Miwa T Miyake T Yamanaka J Sugatani Y Suzuki S Sakata Y Araki M Matsumoto Characterization of serum platelet-activating factor (PAF) acetylhydrolase: Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children J Clin Invest 82 1988 1983 1991
21. DM Stafforini K Satoh DL Atkinson LW Tjoelker C Eberhardt H Yoshida T Imaizumi S Takamatsu GA Zimmerman TM McIntyre PW Gray SM Prescott Platelet-activating factor acetylhydrolase deficiency: A missense mutation near the active site of an anti-inflammatory phospholipase J Clin Invest 97 1996 2784 2791
22. SAS Institute StatView J-5.0 User Manual 1998 SAS Institute, Cary, NC
23. LW Tjoelker C Wilder C Eberhardt DM Stafforini G Dietsch B Schimpf S Hooper H Le Trong LS Cousens GA Zimmerman Y Yamada TM McIntyre SM Prescott PW Gray Anti-inflammatory properties of a platelet-activating factor acetylhydrolase Nature 374 1995 549 553
24. H Xu K Iijima S Shiozawa R Tanaka Y Inoue T Shirakawa K Nishiyama M Miwa H Nakamura N Yoshikawa Platelet-activating factor acetylhydrolase gene mutation in Japanese nephrotic children Kidney Int 54 1998 1867 1871
25. PM Griffin RV Tauxe The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E coli , and the associated hemolytic uremic syndrome Epidemiol Rev 13 1991 60 98
26. TG Obrig PJ Del Vecchio JE Brown TP Moran BM Rowland TK Judge SW Rothman Direct cytotoxic action of Shiga toxin on human vascular endothelial cells Infect Immun 56 1988 2373 2378
27. G Camussi C Tetta F Bussolino G Andres E Turello C Baglioni Involvement of cytokines and platelet-activating factor in renal pathology J Lipid Mediat 2 suppl 2 1990 S203 S213
28. SN Emancipator JR Sedor Cytokines in renal disease DG Remick SL Kunkel Cytokines in Diseases 1992 Marcel Dekker Boston, MA 467 488
29. T Izumi T Shimizu Platelet-activating factor receptor: Gene expression and signal transduction Biochem Biophys Acta 1259 1995 317 333
30. GA Zimmerman SM Prescott TM McIntyre Platelet-activating factor: A fluid phase and cell-associated mediator of inflammation ed 2 JI Gallin IM Goldstein R Snyderman Inflammation: Basic Principles and Clinical Correlates 1992 Raven New York, NY 149 176
31. T Bertani M Livio D Macconi M Morigi G Bisogno C Patrono G Remuzzi Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritis Kidney Int 31 1987 1248 1256
32. G Camussi I Pawlowski R Saunders J Brentjens G Andres Receptor antagonist of platelet-activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin J Lab Clin Med 110 1987 196 206
33. M Gomez Chiarri A Ortiz JL Lerma MJ Lopez Armada F Mampaso E Gonzalez J Egido Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats Lab Invest 70 1994 449 459
34. JM Lopez-Novoa Potential role of platelet-activating factor in acute renal failure Kidney Int 55 1999 1672 1682